Showing results (201-210 of 308) with videos related to
Sort By:
Pageof 31
Tumori|October 31, 1987
Adjuvant chemotherapy with adriamycin, fluorouracil, cyclophosphamide, methotrexate, with or without tamoxifen in operable breast cancerA Lluch-Hernandez, A Cervantes-Ruiperez, A Anton-Torres, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 23, 2016
Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trialF Longo-Muñoz, G Argiles, J Tabernero, et al.The Science of the Total Environment|November 16, 2025
Insights into the transformation of alloxydim during chlorination process; by-product identification, DFT calculations and ecotoxicological assessmentM Cobos-Escudero, A Cervantes-Díaz, J C Nieto-Carmona, et al.Journal of International Society of Preventive & Community Dentistry|July 16, 2021
Cleaning of endodontic files with and without enzymatic detergent by means of the manual method versus the ultrasonic method: An experimental studyCésar F Cayo-Rojas, Estefany Brito-Ávila, Ana S Aliaga-Mariñas, et al.American Journal of Medical Genetics. Part A|June 16, 2005
Trisomy 3q25.1-qter and monosomy 8p23.1-pter in a patient: cytogenetic and molecular analysis with delineation of the phenotypeG Zafra de la Rosa, C A Venegas-Vega, N Monroy, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2014
Quality assurance in the treatment of colorectal cancer: the EURECCA initiativeA J Breugom, P G Boelens, C B M van den Broek, et al.American Journal of Clinical Oncology|April 16, 1998
Seventy-two hour epirubicin infusion plus quinidine in unresectable and metastatic adenocarcinoma of the pancreas: a phase II trialA Abad, B Massuti, E Blanco, et al.British Journal of Cancer|May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancerT Macarulla, A Cervantes, J Tabernero, et al.Clinical Genetics|March 21, 2002
PCR-PRINS-FISH analysis of structurally abnormal sex chromosomes in eight patients with Turner phenotypeA Cervantes, R Guevara-Yáñez, M López, et al.Methods and Findings in Experimental and Clinical Pharmacology|December 13, 2003
Irinotecan (CPT-11) in metastatic colorectal cancer patients resistant to 5-fluorouracil (5-FU): a phase II studyA Antón, E Aranda, A Carrato, et al.Pageof 31